| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |